Predictions
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.70
11.03.23
11.03.23
-
11.03.24
11.03.24
2.80%
12.03.24
12.03.24
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€0.94
11.03.23
11.03.23
-
11.03.24
11.03.24
-76.68%
12.03.24
12.03.24
Sapiens International Corporation NV
Start price
Target price
Perf. (%)
€18.30
11.03.23
11.03.23
-
11.03.24
11.03.24
51.91%
12.03.24
12.03.24
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.70
11.03.23
11.03.23
-
11.03.24
11.03.24
-62.03%
12.03.24
12.03.24
Canadian Solar Inc.
Start price
Target price
Perf. (%)
€36.73
11.03.23
11.03.23
€30.00
11.03.24
11.03.24
0.48%
18.04.23
18.04.23
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Teladoc Health Inc
Start price
Target price
Perf. (%)
€22.61
11.03.23
11.03.23
€20.00
11.03.24
11.03.24
15.44%
18.04.23
18.04.23
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Standard Lithium Ltd
Start price
Target price
Perf. (%)
€3.23
11.03.23
11.03.23
€3.00
11.03.24
11.03.24
10.18%
18.04.23
18.04.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Bad rating
Invitae Corp
Start price
Target price
Perf. (%)
€1.30
11.03.23
11.03.23
€0.40
11.03.24
11.03.24
-93.65%
12.03.24
12.03.24
Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€4.22
11.03.23
11.03.23
€4.60
11.03.24
11.03.24
18.48%
19.05.23
19.05.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Kandi Technologies Corp.
Start price
Target price
Perf. (%)
€2.11
11.03.23
11.03.23
€2.00
11.03.24
11.03.24
21.05%
18.04.23
18.04.23
EBIT growth >5% per year expected
Innovative
Future proof or reliable business model
Sustainability is little important
Equillium Inc.
Start price
Target price
Perf. (%)
€0.52
11.03.23
11.03.23
€0.70
11.03.24
11.03.24
22.72%
24.06.23
24.06.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
Canopy Growth Corp
Start price
Target price
Perf. (%)
€1.93
11.03.23
11.03.23
€0.30
11.03.24
11.03.24
-77.19%
08.07.23
08.07.23
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Appharvest Inc.
Start price
Target price
Perf. (%)
€0.66
11.03.23
11.03.23
€0.020
11.03.24
11.03.24
-87.41%
12.03.24
12.03.24
Could be worthwhile Investment >10% per year
Fair valuation
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardlytics Inc
Start price
Target price
Perf. (%)
€3.46
11.03.23
11.03.23
€2.90
11.03.24
11.03.24
79.29%
18.04.23
18.04.23
Capable Management
Innovative
Very low/no dividend yield expected
ROE lower than 10% per year
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€1.35
11.03.23
11.03.23
€1.90
11.03.24
11.03.24
-78.15%
18.04.23
18.04.23
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Very low/no dividend yield expected
very negative Cash Flow expected
Realty Income Corp
Start price
Target price
Perf. (%)
€58.79
11.03.23
11.03.23
€65.00
11.03.24
11.03.24
-16.94%
12.03.24
12.03.24
LTC Properties Inc.
Start price
Target price
Perf. (%)
€32.22
11.03.23
11.03.23
€40.00
11.03.24
11.03.24
-7.98%
12.03.24
12.03.24